Literature DB >> 7924017

Renal pathology in pre-eclampsia.

L W Gaber1, B H Spargo, M D Lindheimer.   

Abstract

Pre-eclampsia affects the kidney both functionally and morphologically. Renal haemodynamics decrease and urinary protein excretion increases, in part due to lesions affecting the glomerulus, where a combination of changes produces a characteristic appearance and permits differentiation of pre-eclamptic nephropathy from other glomerular alterations associated with hypertension in pregnancy. In pre-eclampsia the glomerulus is diffusely enlarged and bloodless, due not to proliferation, but to hypertrophy of the intracapillary cells. These alterations, best described ultrastructurally, include hypertrophy of the cytoplasmic organelles in endothelial and occasionally mesangial cells, particularly the lysosomes, which undergo marked enlargement and vacuolization (due to accumulation of free neutral lipids). These reactive changes have been termed 'glomerular capillary endotheliosis'. Other lesions, observed occasionally, include subendothelial and mesangial electron-dense deposits, as well as interposition of mesangial cell cytoplasm or mesangial matrix along an otherwise normal basement membrane. Some investigators have described immunohistological findings (presence of IgM, IgG and fibrin) which they believe specific for pre-eclampsia, and others have claimed the disease may cause focal segmental glomerulosclerosis (FSGS). We believe the immunohistological findings are non-specific and insudative, and that FSGS when present predates the pre-eclamptic complication. Finally, the renal lesions appear fully reversible and the disease has no remote cardiorenal effects on its patients.

Entities:  

Mesh:

Year:  1994        PMID: 7924017     DOI: 10.1016/s0950-3552(05)80330-x

Source DB:  PubMed          Journal:  Baillieres Clin Obstet Gynaecol        ISSN: 0950-3552


  14 in total

Review 1.  Preeclampsia. Still an enigma.

Authors:  J Duda
Journal:  West J Med       Date:  1996-04

2.  Sera from preeclampsia patients elicit symptoms of human disease in mice and provide a basis for an in vitro predictive assay.

Authors:  Satyan Kalkunte; Roland Boij; Wendy Norris; Jennifer Friedman; Zhongbin Lai; Jonathan Kurtis; Kee-Hak Lim; James F Padbury; Leif Matthiesen; Surendra Sharma
Journal:  Am J Pathol       Date:  2010-10-01       Impact factor: 4.307

3.  Effects of hypoxia-inducible factor-1alpha overexpression in pregnant mice: possible implications for preeclampsia and intrauterine growth restriction.

Authors:  Reshef Tal; Aviv Shaish; Iris Barshack; Silvia Polak-Charcon; Arnon Afek; Alexander Volkov; Boris Feldman; Camila Avivi; Dror Harats
Journal:  Am J Pathol       Date:  2010-10-15       Impact factor: 4.307

4.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Authors:  Sharon E Maynard; Jiang-Yong Min; Jaime Merchan; Kee-Hak Lim; Jianyi Li; Susanta Mondal; Towia A Libermann; James P Morgan; Frank W Sellke; Isaac E Stillman; Franklin H Epstein; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

5.  Prediction of fluid responsiveness in severe preeclamptic patients with oliguria.

Authors:  Clément Brun; Laurent Zieleskiewicz; Julien Textoris; Laurent Muller; Jean-Pierre Bellefleur; François Antonini; Maxime Tourret; Denis Ortega; Armand Vellin; Jean-Yves Lefrant; Léon Boubli; Florence Bretelle; Claude Martin; Marc Leone
Journal:  Intensive Care Med       Date:  2012-12-06       Impact factor: 17.440

6.  Association between hypertensive disorders during pregnancy and end-stage renal disease: a population-based study.

Authors:  I-Kuan Wang; Chih-Hsin Muo; Yi-Chih Chang; Chih-Chia Liang; Chiz-Tzung Chang; Shih-Yi Lin; Tzung-Hai Yen; Feng-Rong Chuang; Pei-Chun Chen; Chiu-Ching Huang; Chi-Pang Wen; Fung-Chang Sung; Donald E Morisky
Journal:  CMAJ       Date:  2013-01-21       Impact factor: 8.262

Review 7.  Pre-eclampsia: pathogenesis, novel diagnostics and therapies.

Authors:  Elizabeth A Phipps; Ravi Thadhani; Thomas Benzing; S Ananth Karumanchi
Journal:  Nat Rev Nephrol       Date:  2019-05       Impact factor: 28.314

Review 8.  A brief overview of preeclampsia.

Authors:  Noura Al-Jameil; Farah Aziz Khan; Mohammad Fareed Khan; Hajera Tabassum
Journal:  J Clin Med Res       Date:  2013-12-13

9.  Full-length human placental sFlt-1-e15a isoform induces distinct maternal phenotypes of preeclampsia in mice.

Authors:  Gabor Szalai; Roberto Romero; Tinnakorn Chaiworapongsa; Yi Xu; Bing Wang; Hyunyoung Ahn; Zhonghui Xu; Po Jen Chiang; Birgitta Sundell; Rona Wang; Yang Jiang; Olesya Plazyo; Mary Olive; Adi L Tarca; Zhong Dong; Faisal Qureshi; Zoltan Papp; Sonia S Hassan; Edgar Hernandez-Andrade; Nandor Gabor Than
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

10.  Prevalence and determinants of chronic kidney disease in women with hypertensive disorders in pregnancy in Nigeria: a cohort study.

Authors:  Salisu M Ishaku; Timothy Olusegun Olanrewaju; Joyce L Browne; Kerstin Klipstein-Grobusch; Gbenga A Kayode; Arie Franx; Diederick E Grobbee; Charlotte E Warren
Journal:  BMC Nephrol       Date:  2021-06-18       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.